Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Type 1 diabetes stem cell gene therapy - Altheia Science

Next Previous
Drug Profile

Type 1 diabetes stem cell gene therapy - Altheia Science

Latest Information Update: 24 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Altheia Science
  • Class Gene therapies; Haematopoietic stem cells therapies
  • Mechanism of Action B7-H1 antigen stimulants; Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Type 1 diabetes mellitus

Most Recent Events

  • 14 Jul 2026 Phase-I/II clinical trials in Type 1 diabetes mellitus in Italy (Parenteral) (EUCT2025-521304-21-00)
  • 22 Apr 2025 Altheia Science plans the phase I/II IMMUNOSTEM trial for Type 1 diabetes mellitus (Newly diagnosed) in Italy (Parenteral) in August 2025 (NCT06938334) (EUCT2025-521304-21-00)
  • 22 Apr 2025 Preclinical trials in Type 1 diabetes mellitus in Italy (Parenteral) before April 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top